Effects of hydromorphone alone and combined with medetomidine-vatinoxan or dexmedetomidine on alfaxalone induction dose and mean arterial pressure in dogs anesthetized with sevoflurane

Vet Anaesth Analg. 2025 Jan-Feb;52(1):43-52. doi: 10.1016/j.vaa.2024.10.138. Epub 2024 Oct 24.

Abstract

Objective: To evaluate the dose of alfaxalone needed for induction of anesthesia following sedation with medetomidine-vatinoxan plus hydromorphone (MVH), dexmedetomidine plus hydromorphone (DH), or hydromorphone (H) alone. A secondary objective included evaluating selected cardiopulmonary variables before, during, and after sedation and general anesthesia with sevoflurane in healthy dogs.

Study design: Prospective, randomized, masked, crossover.

Animals: Eight healthy Beagle dogs, 3-4 years old.

Methods: All dogs received three intramuscular (IM) treatments: H (0.1 mg kg-1), DH (0.005 mg kg-1 + 0.1 mg kg-1, respectively), or MVH (0.01 mg kg-1 + 0.2 mg kg-1 + 0.1 mg kg-1, respectively) at least 6 days apart. General anesthesia was induced with alfaxalone 20 minutes after treatment administration and maintained for 60 minutes with 2.8% sevoflurane (expired). Sedation scores, selected cardiopulmonary variables, and recovery scores were measured before, during, and after anesthesia at selected timepoints. Mixed-effects ANOVA and ANOVA on ranks were used to evaluate differences between treatments, time, and their interaction, and Tukey-Kramer method was used for post hoc analysis (p < 0.05). Data are presented as mean ± SD or median (range).

Results: Dogs given MVH required a lower dose of alfaxalone for induction of anesthesia (0.77 ± 0.4 mg kg-1) compared to DH and H (1.16 ± 0.34 mg kg-1; p = 0.02, 1.13 ± 0.18 mg kg-1; p = 0.02), and had a higher incidence (50%; p = 0.038) and longer duration [median; 10 (0-35) minutes] of hypotension during sevoflurane anesthesia compared to H [0%; 0 (0-0) minutes; p = 0.040] but not DH (p = 0.272).

Conclusions and clinical relevance: Premedication with MVH provided the greatest alfaxalone-sparing effect. However, this treatment was associated with lower arterial pressures and clinically relevant hypotension. Off-label use of medetomidine-vatinoxan before sevoflurane-based anesthesia should be used with caution due to a high incidence of hypotension.

Keywords: alfaxalone; dexmedetomidine; hydromorphone; medetomidine; sevoflurane; vatinoxan.

Publication types

  • Randomized Controlled Trial, Veterinary

MeSH terms

  • Anesthetics, Combined / administration & dosage
  • Anesthetics, Combined / pharmacology
  • Anesthetics, Inhalation* / administration & dosage
  • Anesthetics, Inhalation* / pharmacology
  • Animals
  • Arterial Pressure / drug effects
  • Cross-Over Studies*
  • Dexmedetomidine* / administration & dosage
  • Dexmedetomidine* / pharmacology
  • Dogs
  • Drug Therapy, Combination
  • Female
  • Hydromorphone* / administration & dosage
  • Hydromorphone* / pharmacology
  • Hypnotics and Sedatives / administration & dosage
  • Hypnotics and Sedatives / pharmacology
  • Male
  • Medetomidine* / administration & dosage
  • Medetomidine* / pharmacology
  • Pregnanediones* / administration & dosage
  • Pregnanediones* / pharmacology
  • Prospective Studies
  • Quinolizines / administration & dosage
  • Quinolizines / pharmacology
  • Sevoflurane* / administration & dosage
  • Sevoflurane* / pharmacology

Substances

  • alphaxalone
  • Anesthetics, Combined
  • Anesthetics, Inhalation
  • Dexmedetomidine
  • Hydromorphone
  • Hypnotics and Sedatives
  • Medetomidine
  • Pregnanediones
  • Quinolizines
  • Sevoflurane
  • vatinoxan